位置:首页 > 产品库 > Mizagliflozin
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Mizagliflozin
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Mizagliflozin图片
CAS NO:666843-10-3
包装与价格:
包装价格(元)
2 mg询价
5 mg询价
10 mg询价
25 mg询价
50 mg询价
100 mg询价
200 mg询价
1 mL*10 mM(in DMSO)询价

DSP-3235 free base
KGA-3235 free base
GSK-1614235 free base
Mizagliflozin是口服有效的、选择性的SGLT1抑制剂,对人 SGLT1 的Ki值为 27 nM。Mizagliflozin对 SGLT1 的选择性是 SGLT2的303 倍。它是抗糖尿病药物,可以改善餐后血糖波动。它在改善慢性便秘方面具有潜在的作用。

产品描述

Mizagliflozin is a sodium-glucose transporter inhibitor( Ki of 27 nM for human SGLT1). Mizagliflozin displays 303-fold selectivity over SGLT2. Mizagliflozin is used as an antidiabetic drug that can modify postprandial blood glucose excursion. Mizagliflozin also exhibits potential in the amelioration of chronic constipation.

体内活性

Mizagliflozin, a novel selective sodium glucose co-transporter 1 (SGLT1) inhibitor, for the amelioration of chronic constipation.?Mizagliflozin's inhibitory activity against SGLTs was evaluated by an in vitro assay of cells transiently expressing SGLTs.?The safety profile of an initial single dose (2-160mg, orally) and multiple doses (2-20mg, orally, once daily immediately prior to breakfast on Days 1 and 13, and three times daily immediately prior to every meal on Days 3-12) of mizagliflozin was determined by performing a phase I study in healthy male subjects.?In addition, the effect of mizagliflozin and lubiprostone on fecal wet weight was compared using a dog model of loperamide-induced constipation and rat model of low-fiber-diet-induced constipation.?Mizagliflozin potently inhibited human SGLT1 in a highly selective manner.?The results of the phase I study showed mizagliflozin increased stool frequency and loosened stool consistency;?these effects increased progressively with an increase in the dosage and the number of doses of mizagliflozin.?In addition, the oral administration of mizagliflozin increased fecal wet weight in a dog model of loperamide-induced constipation and a rat model of low-fiber-diet-induced constipation, similar to lubiprostone.?The potential use of a novel selective SGLT1 inhibitor, mizagliflozin, for the amelioration of chronic constipation[1].

Cas No.

666843-10-3

分子式

C28H44N4O8

分子量

564.67

别名

DSP-3235 free base;KGA-3235 free base;GSK-1614235 free base

储存和溶解度

DMSO:100 mg/mL (177.09 mM),Need ultrasonic
Methanol:250 mg/mL (442.74 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024